Latest by Canadian AIDS Treatment Information Exchange
In a study of more than 900 middle-aged and older HIV-positive people, researchers found nearly 40% of participants were becoming physically weaker and were labelled as "pre-frail."
Researchers found that, on average, HIV-positive people tended to have a heart attack about 15 years before HIV-negative people. However, survival rates in both populations were similar once people were hospitalized.
A Canadian study has raised a troubling finding: Perhaps HIV infection itself may be linked, at least in part, to an increased risk for birth defects and the use of antiretroviral therpay seems to reduce this risk.
Practice Guidelines for Peer Health Navigation for People Living With HIV: A New Program Development Resource for Community-Based Organizations (Part 1)
This new resource for community-based organizations that want to strengthen existing HIV peer health navigation programs or establish new ones provides evidence-based and practice-based recommendations for program planners.
Brief IAS 2017 summaries of ongoing research on pre-exposure prophylaxis (PrEP), evaluating its long-term effectiveness and safety, patient experiences, and alternative dosing schedules, such as an on-demand regimen.
Three service providers relate their views and insights on the challenges facing their clients in getting an undetectable viral load.
A large systematic review of over three dozen studies evaluated the factors that impact the effectiveness of behavioural interventions to prevent sexual transmission of HIV and other sexually transmitted infections.
New York Study Finds Almost Half of HIV-Positive Gay Men Co-Infected With Hepatitis C Have Detectable Levels of Hepatitis C Virus in Their Rectal Fluid
Researchers have found levels of hepatitis C virus in the rectal fluid of HIV-positive MSM co-infected with hepatitis C that are high enough for hepatitis C transmission to occur through condomless anal sex.
Researchers found that nearly 40% of study participants interrupted their first regimen at least once and about 50% of treatment interruptions occurred about a year after antiretroviral therapy had been initiated.
Analyzing the data after one year, researchers found that the new formulation of raltegravir (Isentress HD) was roughly equivalent in effectiveness and safety to the older formulation.